The Tecan Group announced that Ulrich Kanter has been appointed as a member of the Management Board. As Head of the Development & Operations division, effective July 14, 2014, he will assume responsibility for development activities, production, supply chain management and materials purchasing at Tecan. Dr. Martin Brusdeilins, who has headed this division since November 2011, will retire at the end of September 2014 and step down from the Management Board.

Until this time, he will continue to act as Chief Scientific Officer, a position that he holds in addition to being Head of the division. Tecan has initiated the search for a successor to take on this role. Ulrich Kanter worked in various areas and held diverse positions with increasing management responsibility at Roche Diagnostics from 2000.

He was General Manager and Head of Research & Development in Graz, Austria, from 2007, with responsibility for the entire value chain of blood gas and electrolyte analysis systems for this Roche division. Prior to this, he managed the development of these systems as Senior Vice President Research & Development, and as Site Manager was responsible for management of the supply chain as well as all administrative matters at the Graz site.